Innovations in the Clinical Management of Retinal Diseases: Emerging Therapies and Visual Rehabilitation
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: 19 December 2025 | Viewed by 31
Special Issue Editor
Interests: optometry; neuro-ophthalmic disease; glaucoma; retina; neuroscience
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Retinal diseases, including age-related macular degeneration, diabetic retinopathy, retinal vascular occlusions, and retinitis pigmentosa, remain among the leading causes of vision loss worldwide. In recent years, the development of novel therapies has significantly improved the prognosis of these conditions. Anti-VEGF agents and photodynamic therapy have revolutionized the treatment of macular degeneration and retinal vascular occlusions, while advancements in gene therapies, such as MCO-010, have shown promising results in partially restoring visual function in patients with retinitis pigmentosa.
Retinal vascular occlusions, including both venous and arterial thrombosis, are a major cause of sudden vision loss and require innovative therapeutic approaches. Recent research has explored the role of intravitreal therapies and neuroprotection in improving visual outcomes for these patients.
Additionally, emerging strategies such as optogenetics, retinal implants, and neuroprotective treatments are expanding the available therapeutic options, offering new hope to patients with advanced retinal diseases. In this context, visual rehabilitation and low-vision aids play a crucial role in optimizing the quality of life of affected individuals.
This Special Issue aims to bring together innovative research on the diagnosis, treatment, and rehabilitation of retinal diseases, providing an updated perspective on the latest clinical and scientific advancements in this rapidly evolving field.
Dr. Francisco J. Povedano-Montero
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- retinal diseases
- macular degeneration
- maculopathies
- diabetic retinopathy
- retinal vascular occlusions
- retinitis pigmentosa
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
